标题
Antibody based therapeutics for autoimmune hemolytic anemia
作者
关键词
-
出版物
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume -, Issue -, Pages 1-11
出版商
Informa UK Limited
发表日期
2023-10-24
DOI
10.1080/14712598.2023.2274912
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Strategies to overcome the diagnostic challenges of autoimmune hemolytic anemias
- (2023) Wilma Barcellini et al. Expert Review of Hematology
- Fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: Phase 2, multicenter, open‐label study
- (2022) David J. Kuter et al. AMERICAN JOURNAL OF HEMATOLOGY
- A single dose of eculizumab terminated life‐threatening haemolysis in idiopathic IgM‐mediated warm autoimmune haemolytic anaemia: A case report
- (2022) Mamta Garg et al. BRITISH JOURNAL OF HAEMATOLOGY
- Complement C1s inhibition with sutimlimab results in durable response in cold agglutinin disease: CARDINAL study 1-year interim follow-up results
- (2022) Alexander Roth et al. HAEMATOLOGICA
- Cold agglutinin disease secondary to severe SARS-CoV-2 treated with eculizumab
- (2022) Yachar Dawudi et al. BMJ Case Reports
- Sutimlimab in patients with cold agglutinin disease: Results of the randomized placebo-controlled phase 3 CADENZA trial
- (2022) Alexander Röth et al. BLOOD
- The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
- (2022) Joseph D. Khoury et al. LEUKEMIA
- Sutimlimab improves quality of life in patients with cold agglutinin disease: results of patient-reported outcomes from the CARDINAL study
- (2022) Alexander Röth et al. ANNALS OF HEMATOLOGY
- Severe refractory warm autoimmune haemolytic anaemia after the SARS-CoV-2 Pfizer-BioNTech vaccine (BNT162b2 mRNA) managed with emergency splenectomy and complement inhibition with eculizumab
- (2022) Emma Marguerite Jackson et al. BMJ Case Reports
- How I treat warm autoimmune hemolytic anemia
- (2021) Wilma Barcellini et al. BLOOD
- How I Treat Cold Agglutinin Disease
- (2021) Sigbjorn Berentsen BLOOD
- Features of serum complement C3 and C4 levels in autoimmune hemolytic anemia patients
- (2021) Zhao Wang et al. International Journal of Laboratory Hematology
- The Immunomodulatory Effect and Clinical Efficacy of Daratumumab in a Patient With Cold Agglutinin Disease
- (2021) Anna Zaninoni et al. Frontiers in Immunology
- Eculizumab, a real-life successful treatment for refractory cold agglutinin–mediated auto-immune hemolytic anemia secondary to lymphoproliferative disorders
- (2021) Laura Herbreteau et al. ANNALS OF HEMATOLOGY
- Sutimlimab in Cold Agglutinin Disease
- (2021) Alexander Röth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease/cold agglutinin syndrome
- (2021) Marit Jalink et al. BLOOD
- Daratumumab in rituximab‐refractory autoimmune haemolytic anaemia
- (2021) Max J. Rieger et al. BRITISH JOURNAL OF HAEMATOLOGY
- Sutimlimab, an investigational C1s inhibitor, effectively prevents exacerbation of hemolytic anemia in a patient with cold agglutinin disease undergoing major surgery
- (2021) Tor Henrik A. Tvedt et al. AMERICAN JOURNAL OF HEMATOLOGY
- Autoimmune Hemolytic Anemias
- (2021) Sigbjørn Berentsen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Daratumumab for refractory warm autoimmune hemolytic anemia
- (2020) Ankur Jain et al. ANNALS OF HEMATOLOGY
- Cold agglutinin disease revisited: A multinational, observational study of 232 patients
- (2020) Sigbjorn Berentsen et al. BLOOD
- Daratumumab for disabling cold agglutinin disease refractory to B‐cell directed therapy
- (2020) Oliver Tomkins et al. AMERICAN JOURNAL OF HEMATOLOGY
- Efficacy and safety of rituximab in autoimmune and microangiopathic hemolytic anemia: a systematic review and meta-analysis
- (2020) Shih-Hsuan Chao et al. Experimental Hematology & Oncology
- New Insights in Autoimmune Hemolytic Anemia: From Pathogenesis to Therapy
- (2020) Wilma Barcellini et al. Journal of Clinical Medicine
- Bone marrow characteristics predict outcome in a multicenter cohort of primary immune thrombocytopenia patients treated with thrombopoietin analogues.
- (2019) Bruno Fattizzo et al. HAEMATOLOGICA
- Post‐allogeneic transplant Evans syndrome successfully treated with daratumumab
- (2019) Richard Blennerhassett et al. BRITISH JOURNAL OF HAEMATOLOGY
- Anemias hemolíticas autoinmunes: estudio retrospectivo de 93 pacientes
- (2019) Isabel Gutiérrez Jomarrón et al. MEDICINA CLINICA
- Successful treatment with daratumumab for post‐HSCT refractory hemolytic anemia
- (2019) Ehud Even‐Or et al. PEDIATRIC BLOOD & CANCER
- Splenectomy and the incidence of venous thromboembolism and sepsis in patients with autoimmune hemolytic anemia
- (2019) Gwendolyn Ho et al. BLOOD CELLS MOLECULES AND DISEASES
- Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting
- (2019) Ulrich Jäger et al. BLOOD REVIEWS
- Daratumumab in combination with standard treatment for autoimmune hemolytic anemia in a pediatric patient
- (2019) Laura Cooling et al. TRANSFUSION
- Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from 8 Italian Reference Centers
- (2018) Wilma Barcellini et al. AMERICAN JOURNAL OF HEMATOLOGY
- Prognostic impact of bone marrow fibrosis and dyserythropoiesis in autoimmune hemolytic anemia
- (2018) Bruno Fattizzo et al. AMERICAN JOURNAL OF HEMATOLOGY
- Short course of bortezomib in anemic patients with relapsed cold agglutinin disease. A phase II prospective GIMEMA study
- (2018) Giuseppe Rossi et al. BLOOD
- High efficacy of eculizumab treatment for fulminant hemolytic anemia in primary cold agglutinin disease
- (2018) Kenichi Makishima et al. ANNALS OF HEMATOLOGY
- Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial
- (2018) Ulrich Jäger et al. BLOOD
- A randomized and double-blind controlled trial evaluating the safety and efficacy of rituximab for warm auto-immune hemolytic anemia in adults (the RAIHA study)
- (2016) Marc Michel et al. AMERICAN JOURNAL OF HEMATOLOGY
- Efficacy and safety of rituximab in auto-immune hemolytic anemia: A meta-analysis of 21 studies
- (2015) Quitterie Reynaud et al. AUTOIMMUNITY REVIEWS
- Serum BAFF and APRIL levels in patients with autoimmune hemolytic anemia and their clinical significance
- (2015) Zi-Zhen Xu et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Refractory warm IgM-mediated autoimmune hemolytic anemia associated with Churg-Strauss syndrome responsive to eculizumab and rituximab
- (2014) Mark P. Chao et al. AMERICAN JOURNAL OF HEMATOLOGY
- TNT003, an inhibitor of the serine protease C1s, prevents complement activation induced by cold agglutinins
- (2014) J. Shi et al. BLOOD
- Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients
- (2014) W. Barcellini et al. BLOOD
- Long-term response of refractory primary cold agglutinin disease to eculizumab therapy
- (2013) Neha Gupta et al. ANNALS OF HEMATOLOGY
- A phase III randomized trial comparing glucocorticoid monotherapyversusglucocorticoid and rituximab in patients with autoimmune haemolytic anaemia
- (2013) Henrik Birgens et al. BRITISH JOURNAL OF HAEMATOLOGY
- A multi-centre retrospective study of rituximab use in the treatment of relapsed or resistant warm autoimmune haemolytic anaemia
- (2013) Su W. Maung et al. BRITISH JOURNAL OF HAEMATOLOGY
- Sustained response to low-dose rituximab in idiopathic autoimmune hemolytic anemia
- (2013) Wilma Barcellini et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia
- (2010) Francisco Javier Peñalver et al. ANNALS OF HEMATOLOGY
- High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease
- (2010) S. Berentsen et al. BLOOD
- Rituximab in Autoimmune Hematologic Diseases: Not Just a Matter of B Cells
- (2010) Roberto Stasi SEMINARS IN HEMATOLOGY
- Long-term efficacy of the complement inhibitor eculizumab in cold agglutinin disease
- (2009) A. Roth et al. BLOOD
- Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study
- (2009) D. Dierickx et al. JOURNAL OF INTERNAL MEDICINE
- Efficacy and safety of rituximab in adults' warm antibody autoimmune haemolytic anemia: Retrospective analysis of 27 cases
- (2008) Guillaume Bussone et al. AMERICAN JOURNAL OF HEMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search